AJO
Audio Journal of Oncology - July 15th 2006
 David Cunningham |
 Kenneth MacDonald |
 Mark Pomerantz |
 Jorge Garcia |
REFERENCE: N Engl J Med 2006;355:11
David Cunningham, Royal Marsden Hospital
The July 6th edition of the New England Journal of Medicine leads with an article from the Royal Marsden Hospital pointing to better survival rates among patients with gastric cancer who received perioperative chemotherapy as compared with those having surgery alone. David Cunningham tells Peter Goodwin how the study (which took 16 years from design to publication) has provided clinicians with another option for extending life in gastric cancer.
David Cunningham, Royal Marsden Hospital
The July 6th edition of the New England Journal of Medicine leads with an article from the Royal Marsden Hospital pointing to better survival rates among patients with gastric cancer who received perioperative chemotherapy as compared with those having surgery alone. David Cunningham tells Peter Goodwin how the study (which took 16 years from design to publication) has provided clinicians with another option for extending life in gastric cancer.
REFERENCE: Abstract 4570
Kenneth MacDonald, University of Utah, Salt Lake City
At the 2006 Annual Meeting of the American Society of Clinical Oncology in Atlanta Kenneth MacDonald from the University of Utah in Salt Lake City explained to Sarah Maxwell how registry data has provided guidance that salvage radiotherapy for prostate-specific antigen relapse after radical prostatectomy may yield benefits in greater numbers of patients.
Kenneth MacDonald, University of Utah, Salt Lake City
At the 2006 Annual Meeting of the American Society of Clinical Oncology in Atlanta Kenneth MacDonald from the University of Utah in Salt Lake City explained to Sarah Maxwell how registry data has provided guidance that salvage radiotherapy for prostate-specific antigen relapse after radical prostatectomy may yield benefits in greater numbers of patients.
REFERENCE: Abstract 4560
Mark Pomerantz, Dana-Farber Cancer Institute, Boston
The same prostate cancer session of ASCO also heard from Mark Pomerantz of the Dana-Farber Cancer Institute in Boston that premarin – the hormonal therapy known for its use in women – may have value for treating men with androgen-dependent prostate cancer.
Mark Pomerantz, Dana-Farber Cancer Institute, Boston
The same prostate cancer session of ASCO also heard from Mark Pomerantz of the Dana-Farber Cancer Institute in Boston that premarin – the hormonal therapy known for its use in women – may have value for treating men with androgen-dependent prostate cancer.
REFERENCE: Abstract 4564
Jorge Garcia, Cleveland Clinic
In high-risk prostate cancer, neoadjuvant therapy with thalidomide plus granulocyte macrophage colony-stimulating factor appears to be a candidate therapy to prepare some patients for radical prostatectomy by manipulating immunological factors reported Jorge Garcia from the Cleveland Clinic during the ASCO conference in Atlanta.
Jorge Garcia, Cleveland Clinic
In high-risk prostate cancer, neoadjuvant therapy with thalidomide plus granulocyte macrophage colony-stimulating factor appears to be a candidate therapy to prepare some patients for radical prostatectomy by manipulating immunological factors reported Jorge Garcia from the Cleveland Clinic during the ASCO conference in Atlanta.
Similar Interviews
Audio Journal of Oncology - July 1st 2006Audio Journal of Oncology in Advance -July 15th, 2007 - reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007
Health For All 30 Years After Alma Ata? Mental Health And War»
AliaIbrahim Zai, Egbert Sondorp, Gill Walt, Lucy Gilson, Ravi Narayan, Richard Horton, Vikram Patel, Willem Van De Put
Two important symposia have been held in London to discuss healthcare issues posing significant dilemmas to world leaders in the 21st Century. "The Future of Primary Health Care" was attended by public health experts from around the Globe to assess the best options for improving primary health care in the future. It was held on the 30th anniversary of the Alma Ata Declaration made in 1977 which was intended as a blueprint for health provision and identified primary health care as the means through which the global goal of "Health for All" could be achieved. The second meeting, on "Mental Health in Fragile States", was held to raise the profile of mental health care in zones where conflict has taken place or is still happening. Analyses of the key issues and how to deal with them effectively were discussed by top experts from the London School of Hygiene and Tropical Medicine and associated organisations. Peter Goodwin attended both meetings and talked with some of the key speakers.AliaIbrahim Zai, Egbert Sondorp, Gill Walt, Lucy Gilson, Ravi Narayan, Richard Horton, Vikram Patel, Willem Van De Put
LSHTM Audio News: British Association Special Edition»
Astrid Fletcher, Jo Lines, Sari Kovats, Colin Sutherland, Michel Coleman
Peter Goodwin hears from London School of Hygiene and Tropical Medicine experts speaking at the annual science festival of the British Association for the Advancement of Science held in Liverpool, September 6-10, 2008, and from recent scientific publications on: the health impact of global warming, a tropical virus reaching temperate zones, inequalities in cancer outcomes, how eating oily fish can save your eyesight, and free internet publishing scientific journals.Astrid Fletcher, Jo Lines, Sari Kovats, Colin Sutherland, Michel Coleman
© 2008 Audio Medica - Medical Audio News Interviews & Podcasts. 
Post a comment